TrialBMC cancer2024

Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study.

Michael Boyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.